Figure 4From: Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trialNet benefit curves, societal perspective; effectiveness measured on the EQ VAS. Dashed lines represent 95% confidence intervals.Back to article page